DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
DESIDUSTAT
3
Small molecule
Investigational
Unknown
Unknown
Renal Insufficiency, Chronic; Severe Acute Respiratory Syndrome; Kidney Failure, Chronic
Unknown
DESIDUSTAT
×
Maximum Phase:
3
First Approval:
None
UNII:
Y962PQA4KS
Molecule Type:
Small molecule
Molecular Formula:
C16H16N2O6
Molecular Weight:
332.31
AlogP:
0.36
PSA:
117.86
HBD:
3.0
HBA:
#RotB:
6.0
Source:
HUNTERASE
3
Enzyme
Investigational
Unknown
Unknown
Unknown
Unknown
HUNTERASE
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ONO-5920
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ONO-5920
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYALURONIDASE (OVINE)
3
Enzyme
Investigational
Unknown
Unknown
Unknown
Hyaluronic acid hydrolytic enzyme
HYALURONIDASE (OVINE)
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VERCIRNON SODIUM
3
Small molecule
Investigational
Unknown
Unknown
Crohn Disease
Unknown
VERCIRNON SODIUM
×
Maximum Phase:
3
First Approval:
None
UNII:
9NQF0M8R0M
Molecule Type:
Small molecule
Molecular Formula:
C22H20ClN2NaO4S
Molecular Weight:
466.92
AlogP:
4.3
PSA:
90.18
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ANGIOTENSIN
3
Protein
Investigational
Unknown
Unknown
Hypertension; Renal Insufficiency, Chronic
Unknown
ANGIOTENSIN
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
C43H65N13O12
Molecular Weight:
956.07
AlogP:
-2.72
PSA:
406.34
HBD:
14.0
HBA:
#RotB:
26.0
Source:
OTAMIXABAN
3
Small molecule
Investigational
Unknown
Unknown
Kidney Diseases; Liver Diseases; Coronary Disease; Acute Coronary Syndrome
Coagulation factor X inhibitor
OTAMIXABAN
×
Maximum Phase:
3
First Approval:
None
UNII:
S173RED00L
Molecule Type:
Small molecule
Molecular Formula:
C25H26N4O4
Molecular Weight:
446.51
AlogP:
2.42
PSA:
132.21
HBD:
3.0
HBA:
#RotB:
8.0
Source:
MALTOSE
3
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Bipolar Disorder
Unknown
MALTOSE
×
Maximum Phase:
3
First Approval:
None
UNII:
R4B6462NGR
Molecule Type:
Small molecule
Molecular Formula:
C12H22O11
Molecular Weight:
342.3
AlogP:
-5.4
PSA:
189.53
HBD:
8.0
HBA:
#RotB:
4.0
Source:
HSK-3486
3
Small molecule
Investigational
Unknown
Unknown
Kidney Diseases
GABA-A receptor; anion channel agonist
HSK-3486
×
Maximum Phase:
3
First Approval:
None
UNII:
M3WGS532VY
Molecule Type:
Small molecule
Molecular Formula:
C14H20O
Molecular Weight:
204.31
AlogP:
4.03
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
3.0
Source:
EPROTIROME
3
Small molecule
Investigational
Unknown
Unknown
Hypercholesterolemia; Lipid Metabolism Disorders; Hyperlipoproteinemia Type II
Thyroid hormone receptor beta-1 agonist
EPROTIROME
×
Maximum Phase:
3
First Approval:
None
UNII:
958AQ7B6R1
Molecule Type:
Small molecule
Molecular Formula:
C18H17Br2NO5
Molecular Weight:
487.14
AlogP:
5.25
PSA:
95.86
HBD:
3.0
HBA:
#RotB:
6.0
Source:
ENSOVIBEP
3
Protein
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Unknown
ENSOVIBEP
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEREVALEFIM
3
Small molecule
Investigational
Unknown
Unknown
Acute Kidney Injury
Hepatocyte growth factor receptor agonist
TEREVALEFIM
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C9H8N2S
Molecular Weight:
176.24
AlogP:
2.64
PSA:
28.68
HBD:
1.0
HBA:
#RotB:
2.0
Source:
CRENOLANIB
3
Small molecule
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Stomach Neoplasms; Glioblastoma; Glioma; Gastrointestinal Stromal Tumors; Leukemia, Myeloid, Acute
Platelet-derived growth factor receptor inhibitor
CRENOLANIB
×
Maximum Phase:
3
First Approval:
None
UNII:
LQF7I567TQ
Molecule Type:
Small molecule
Molecular Formula:
C26H29N5O2
Molecular Weight:
443.55
AlogP:
3.92
PSA:
78.43
HBD:
1.0
HBA:
#RotB:
5.0
Source:
PENPULIMAB
3
Antibody
Investigational
Unknown
Unknown
Hodgkin Disease; Neoplasms; Pancreatic Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Lung Neoplasms; Nasopharyngeal Neoplasms
Programmed cell death protein 1 inhibitor
PENPULIMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OSI-906
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
OSI-906
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EFAPROXIRAL
3
Small molecule
Investigational
Unknown
Unknown
Central Nervous System Neoplasms; Breast Neoplasms; Lung Neoplasms; Neoplasms
Hemoglobin HbA negative modulator
EFAPROXIRAL
×
Maximum Phase:
3
First Approval:
None
UNII:
J81E81G364
Molecule Type:
Small molecule
Molecular Formula:
C20H23NO4
Molecular Weight:
341.41
AlogP:
3.73
PSA:
75.63
HBD:
2.0
HBA:
#RotB:
6.0
Source:
RAPASTINEL
3
Protein
Investigational
Unknown
Unknown
Obsessive-Compulsive Disorder; Depressive Disorder, Major
Glutamate [NMDA] receptor partial agonist
RAPASTINEL
×
Maximum Phase:
3
First Approval:
None
UNII:
6A1X56B95E
Molecule Type:
Protein
Molecular Formula:
C18H31N5O6
Molecular Weight:
413.48
AlogP:
-2.97
PSA:
179.29
HBD:
5.0
HBA:
#RotB:
7.0
Source:
DARUSENTAN
3
Small molecule
Investigational
Unknown
Unknown
Hypertension
Endothelin receptor ET-A antagonist
DARUSENTAN
×
Maximum Phase:
3
First Approval:
None
UNII:
33JD57L6RW
Molecule Type:
Small molecule
Molecular Formula:
C22H22N2O6
Molecular Weight:
410.43
AlogP:
2.92
PSA:
100.0
HBD:
1.0
HBA:
#RotB:
9.0
Source:
E7337
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
E7337
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALBINTERFERON ALFA-2B
3
Protein
Investigational
Unknown
Unknown
Hepatitis B, Chronic; Hepatitis C; Hepatitis C, Chronic
Interferon alpha/beta receptor agonist
ALBINTERFERON ALFA-2B
×
Maximum Phase:
3
First Approval:
None
UNII:
4DVS4AG4DF
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BOCOCIZUMAB
3
Antibody
Investigational
Unknown
Unknown
Hypercholesterolemia; Cardiovascular Diseases; Hyperlipidemias; Hyperlipoproteinemia Type II
Subtilisin/kexin type 9 inhibitor
BOCOCIZUMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
45M75JVK38
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SILICON DIOXIDE
3
Unknown
Investigational
Unknown
Unknown
Fluorosis, Dental; Hypersensitivity
Unknown
SILICON DIOXIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
ETJ7Z6XBU4
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HETROMBOPAG OLAMINE
3
Unknown
Investigational
Unknown
Unknown
Anemia, Aplastic; Purpura, Thrombocytopenic, Idiopathic
Unknown
HETROMBOPAG OLAMINE
×
Maximum Phase:
3
First Approval:
None
UNII:
V45T2I862X
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DROPROPIZINE
3
Small molecule
Investigational
Unknown
Unknown
Cough; Inflammation; Rhinitis
Unknown
DROPROPIZINE
×
Maximum Phase:
3
First Approval:
None
UNII:
U0K8WHL37U
Molecule Type:
Small molecule
Molecular Formula:
C13H20N2O2
Molecular Weight:
236.32
AlogP:
0.16
PSA:
46.94
HBD:
2.0
HBA:
#RotB:
4.0
Source:
TECHNETIUM
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TECHNETIUM
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Tc
Molecular Weight:
98.0
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
SMALLPOX VACCINE
3
Unknown
Investigational
Unknown
Unknown
Fever; HIV Infections; Smallpox
Unknown
SMALLPOX VACCINE
×
Maximum Phase:
3
First Approval:
None
UNII:
4SV59689SK
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ROSIPTOR
3
Small molecule
Investigational
Unknown
Unknown
Dermatitis, Atopic; Pulmonary Disease, Chronic Obstructive; Cystitis, Interstitial
Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1 activator
ROSIPTOR
×
Maximum Phase:
3
First Approval:
None
UNII:
6R5034F862
Molecule Type:
Small molecule
Molecular Formula:
C20H35NO2
Molecular Weight:
321.5
AlogP:
3.1
PSA:
66.48
HBD:
3.0
HBA:
#RotB:
3.0
Source:
RELTECIMOD
3
Protein
Investigational
Unknown
Unknown
Infections
Unknown
RELTECIMOD
×
Maximum Phase:
3
First Approval:
None
UNII:
U00J02UY29
Molecule Type:
Protein
Molecular Formula:
C46H72N10O15S
Molecular Weight:
1037.2
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MITOMYCIN A
3
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular
Unknown
MITOMYCIN A
×
Maximum Phase:
3
First Approval:
None
UNII:
87TMG6FJHV
Molecule Type:
Small molecule
Molecular Formula:
C16H19N3O6
Molecular Weight:
349.34
AlogP:
-0.96
PSA:
130.1
HBD:
2.0
HBA:
#RotB:
4.0
Source:
PHYSIONEAL
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PHYSIONEAL
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GOSSYPOL
3
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Unknown
GOSSYPOL
×
Maximum Phase:
3
First Approval:
None
UNII:
XNA7DR63CQ
Molecule Type:
Small molecule
Molecular Formula:
C30H30O8
Molecular Weight:
518.56
AlogP:
6.38
PSA:
155.52
HBD:
6.0
HBA:
#RotB:
5.0
Source:
ALFERMINOGENE TADENOVEC
3
Gene
Investigational
Unknown
Unknown
Unknown
Unknown
ALFERMINOGENE TADENOVEC
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Gene
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ST. JOHN'S WORT
3
Unknown
Investigational
Unknown
Unknown
Attention Deficit Disorder with Hyperactivity; Irritable Bowel Syndrome; Tobacco Use Disorder; Breast Neoplasms; Depressive Disorder; Genital Neoplasms, Male; Head and Neck Neoplasms; Kidney Neoplasms; Pain; Raynaud Disease
Unknown
ST. JOHN'S WORT
×
Maximum Phase:
3
First Approval:
None
UNII:
UFH8805FKA
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ANAPRAZOLE
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ANAPRAZOLE
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C21H24N2O4S
Molecular Weight:
400.5
AlogP:
3.53
PSA:
73.44
HBD:
1.0
HBA:
#RotB:
8.0
Source:
KARENITECIN
3
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Central Nervous System Neoplasms; Brain Neoplasms; Lung Neoplasms; Melanoma; Ovarian Neoplasms
Unknown
KARENITECIN
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C25H28N2O4Si
Molecular Weight:
448.6
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
1
2
…
203
204
205
206
207
208
209
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA